FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/05/008527 [Registered on: 09/05/2017] Trial Registered Retrospectively
Last Modified On: 04/05/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Anu Tail Nasya on the nasal bacterial micro flora in Healthy volunteers  
Scientific Title of Study   The Physiological Study of Anu Tail Nasya on Healthy Volunteer’s With the Help of Normal Nasal Bacterial Micro flora - A pilot Study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vyas Deepak M 
Designation  PhD (Scholar) 
Affiliation  MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Hadapsar Pune 
Address  Dept. of Kriya sharir MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Hadapsar Pune

Pune
MAHARASHTRA
411028
India 
Phone  09404554773  
Fax    
Email  dr.deepakmvyas@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kalpana D Sathe 
Designation  Prof. and HOD 
Affiliation  MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Pune  
Address  Head-Dept. of Kriya Sharir MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Malwadi Hadapsar Pune

Pune
MAHARASHTRA
411028
India 
Phone  09881691940  
Fax    
Email  sathekd61@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Suwarna V Umarkar 
Designation  Assistant Proffesor 
Affiliation  Government Ayurved College Nagpur 
Address  Department of Kriya Sharir Government Ayurved College Sakkardara Nagpur

Nagpur
MAHARASHTRA
4400024
India 
Phone  9423404273  
Fax    
Email  dr.suwarnavumarkar@gmail.com  
 
Source of Monetary or Material Support  
Dept. of Kriya Sharir, MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Malwadi Hadapsar Pune 411028 
 
Primary Sponsor  
Name  Deepak M Vyas 
Address  MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Malwadi Hadapsar Pune Maharashtra 411028 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Deepak M Vyas  MAMs Sumatibhai Shah Ayurved Mahavidhyalaya  Dept. of Kriya Sharir, MAMs Sumatibhai Shah Ayurved Mahavidhyalaya Hadapsar Pune, Maharashtra 411028
Pune
MAHARASHTRA 
09404554773

dr.deepakmvyas@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Review Board for Research Maharashtra Arogya Mandals Sumatibhai Shah Ayurveda Mahavidyalaya and Ayurveda Hospital Sane Guruji Arogya Kendra Malwadi Hadapsar Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Human Volunteers to check effect of Anu Tail Nasya 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Anu Tail Nasya  Anu Tail is multiple ingredients Ayurvedic formulation.It helps to strengthen the urdhvajatrugat avayavas.It is administered after snehan and swedan of urdhvajatrugat avayavas.Anu Tail is administered in both the nostril in madhyanna kala. Dose 4 to 8 drops in each nostril for 7 days. Nasya is followed by lukewarm water Gandush. 
Comparator Agent  No Intervention  To check the effect of weather on normal nasal bacterial flora. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1.Healthy individual
2.Individual of either sex i.e. Male or Female
3.Age: - 20 – 40 yrs
4.Volunteers residing in study area since last 15 days & not planned to go away in next 15 days after Nasya Karma
5.Willing for consent
 
 
ExclusionCriteria 
Details  1.Volunteers with addiction of smoking & chronic Alcohol intake
2.Volunteers participated in any other clinical trial 4 weeks prior to enrolment into this study
3.Volunteer with family history of Congenital or hereditary disorders
4.Volunteer with history of any acute or chronic medical or surgical illness
5.Volunteer with history of any nasal or systemic medication in last 4 weeks
6.Volunteer with history of Panchakarma Vyapad
7.Volunteer with history of travelling in last 4 weeks
8.Pregnant & Lactating women
9.Volunteer with acute or chronic clinically significant pulmonary, cardiovascular, genitourinary or any systemic abnormality as determined by history or clinical examination
10.Volunteer with Nasya karma Ayogya
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Effect of Anu Tail Nasya on major component of commensal nasal bacterial micro-flora
2.Effect of Anu Tail Nasya on common sinus pathogen of nasal bacterial micro-flora 
2 months 
 
Secondary Outcome  
Outcome  TimePoints 
Effect of weather on nasal bacterial micro-flora in healthy volunteers  2 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   N/A 
Date of First Enrollment (India)   17/11/2011 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Non Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Study design

This study was  a randomised parallel group clinical trial  to study the effect of Anu Tail Nasya on healthy volunteers with the help of normal nasal bacterial micro-flora. There were two groups one intervention group i.e., Group A receiving Anu Tail Nasya therapy for seven days and second group i.e., Group B without any intervention.

Hypothesis

The study was conducted to observe the effect of Anu tail Nasya on nasal bacterial flora whether Anu tail Nasya will help to maintain commensal bacterial flora and also it will reduce pathogenic bacteria flora.

Sampling Technique

The volunteers were selected irrespective of their sex, religion, and occupation etc., The Simple random sampling method(lottery method) was adopted for grouping.

Design

Parallel-Group Randomized clinical trial 

The study had received prior approval from the Institutional ethics committee.

(Ref. No. MAM/SS Ayu/711 Date 29/12/2010)

Sample size After screening, 100 volunteers filter through following criteria 

Methods:-

1.      Screening of volunteer: -Volunteers were screened with the help of screening form. The screening proforma consist of inclusion and exclusion criteria. The Health status of the volunteer was decided with the help of  Health status form. It includes the Charakokta and Kashyapokta Swastha Lakshana. Those fulfilled the above criteria was investigated for complete blood count. The screened volunteers having complete Blood count within normal range were enrolled for further study after signing informed consent.

2.      Ethical consideration and informed Consent:-

The eligible volunteers were fully informed about the study in their own first language. The researcher freely obtained written informed consent of the volunteer for their participation in the study. The consent form was fully explained to the Volunteer. The Volunteer was given ample opportunity to ask questions and be assured that non-participation in the study would not compromise any right and, once enrolled the volunteer  could  withdraw consent or to be discontinued from the study at any point.

§  Enrollment day was considered as ’ day 0’ and baseline information were collected. After the enrollment, each volunteer was given a separate ID form to hide their identity.

3.      Enrolled volunteers were randomly allocated into two groups i.e.Group A and Group B with the help of lottery method.

4.      Grouping of Volunteers

Group A- Intervention group

§   Number of volunteers- 50

§  Anu Tail Nasya therapy for seven days 

§  Route of Dravya Administration-Nasa

§  Dose of Nasya- 8 drops in each nostril followed by Gandusha

§  Nasal swab was obtained on day 0 (baseline), 10th day and 20th day from the day of enrollment.

Group B-Control group

§  Number of volunteers- 50

§  No  intervention

§  Nasal swab was obtained on day 0 (baseline), 10th day and 20th day from the day of enrolment.

Scheduled follow-up

§  0 day – Enrolment day

§  10th   Day - 1st follow up

§  20th Day - 2nd follow up

Culture Technique:- The culture technique was performed according to technique mentioned in Mackie (1).

Culture Report Result

The result of microbial study was compiled under three groups i.e. I) Major component of normal nasal flora, II) Common sinus pathogens and III) other bacteria. The group of major component of normal flora includes α-hemolytic streptococci, Coagulase-negative staphylococci, Coagulase positive staphylococci. II) Common sinus pathogen is β- hemolytic streptococci. III) Other bacteria include Bacillus subtilis, Enterobacteriaceae species (It includes E. coli, K. pneumoniae and P. mirabilis), Pseudomonas and Nonhemolytic streptococci.

Unscheduled follow-up

 Volunteers who came at study centre other than their actual scheduled follow-up for any complaints considered as unscheduled follow- up.

Serious adverse events (SAE)

If any Serious Adverse Events happened then, it will be recorded and immediately reported to the Ethics Committee.

Drop out criteria:-

1.      Voluntary withdrawal of consent (VW) – Volunteer not willing to continue his participation in the study and expressed their desire to withdraw consent at any time in the study period.

2.      Moved out of study area (MO) – If the Volunteer expressed his desire to discontinue the study and was not willing to follow up because he shifted from his current residing place and moved out of the study area beyond 50kms from the study site.

3.      Lost to follow-up (LTF) - Any Volunteer who did not turn up at the study centre on schedule visit and could not be traced on home visit/cell phone contact was considered as lost to follow-up.

4.      If any serious adverse events (SAE)

 

 
Close